R11.16
Cannabis hyperemesis syndrome
Clinical Classification Guidelines
Inclusion Terms
- Cannabinoid hyperemesis syndrome
Code Also
- cannabis abuse (F12.1-)
- cannabis dependence (F12.2-)
- cannabis use, unspecified (F12.92-, F12.93, F12.95-, F12.98-, F12.99)
- manifestations, such as:
- dehydration (E86.0)
- electrolyte imbalance (E87.8}
Medical Intelligence & Overview
Cannabis hyperemesis syndrome (CHS) is a condition characterized by recurrent episodes of severe nausea and vomiting linked to long-term cannabis use. Despite cannabis often being used for medicinal and recreational purposes, excessive or prolonged use can lead to this distressing syndrome. Recognized under ICD-10 code R11.16, CHS can significantly impact an individual's quality of life, making awareness and understanding of this condition important.
Causes & Symptoms
Clinical Causes: Chronic, long-term use of cannabis Genetic predisposition may influence susceptibility High doses of cannabis intake over extended periods Possible alterations in the body's endocannabinoid system due to frequent use
Key Symptoms: Profound nausea and persistent vomiting Relief from symptoms through hot showers or baths Abdominal pain or discomfort Dehydration due to excessive vomiting Electrolyte imbalances from fluid loss Compulsive hot bathing behaviors to alleviate symptoms
Diagnostic & Treatment
Diagnosis Path: Diagnosing cannabis hyperemesis syndrome involves a thorough review of the patient's medical history, including detailed questions about cannabis use. Healthcare providers typically perform physical examinations and may order laboratory tests to rule out other causes of nausea and vomiting, such as gastrointestinal infections, metabolic issues, or other medical conditions. Diagnostic criteria often include recurrent episodes of vomiting in conjunction with a history of chronic cannabis use, symptom relief with hot bathing, and exclusion of alternative diagnoses.
Treatment Protocols: Managing CHS generally involves several approaches aimed at alleviating symptoms and addressing cannabis consumption. Common strategies include: - **Cessation of Cannabis Use:** The primary and most effective step is stopping cannabis intake, which may lead to symptom resolution. - **Supportive Care:** Intravenous fluids to correct dehydration, electrolyte replenishment, and medications to control nausea and vomiting. - **Symptom Management:** Use of antiemetic drugs and analgesics as recommended by healthcare providers. - **Hot Water Therapy:** Patients often find temporary relief through hot showers or baths, which should be supervised to prevent burns. - **Psychosocial Support:** Counseling or behavioral therapies can support cessation efforts. It is important to seek medical guidance for proper management, as self-treatment can sometimes mask underlying issues or lead to complications.
Clinical Advice & FAQs
Billing Guidance
Is R11.16 a billable ICD-10 code?
Yes, R11.16 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R11.16?
Clinical documentation must specify the nature of Cannabis hyperemesis syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
